Insider · CIK 0001207792
Robert J More
Files at VIR (Vir Biotechnology, Inc.), TYRA (Tyra Biosciences, Inc.). First filing Nov 25, 2025, latest Dec 19, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TYRA: Tyra Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 16Weak | Tyra Biosciences, Inc. | $250k 10,000 shares | -0% | +261% from low0% from high | |
| 28Weak | Tyra Biosciences, Inc. | $5.0M 246,871 shares | -6% | +199% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -10,000 | $25.00 | $250k | 3,823,425 | Dec 19, 2025 |
| Nov 21, 2025 | TYRA Tyra Biosciences, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -246,871 | $20.25 | $5.0M | 3,833,425 | Nov 25, 2025 |
| Jun 9, 2025 | VIR Vir Biotechnology, Inc. | JOther Common Stock | -14,027 | $0.00 | $0 | 40,656 | Jun 9, 2025 |
| Jun 9, 2025 | VIR Vir Biotechnology, Inc. | JOther Common Stockindirect: See footnote | +14,027 | $0.00 | $0 | 509,917 | Jun 9, 2025 |
| May 30, 2025 | VIR Vir Biotechnology, Inc. | AGrant or award Common Stock | +8,000 | $0.00 | $0 | 54,683 | Jun 2, 2025 |
| May 29, 2025 | TYRA Tyra Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +22,200 | $0.00 | $0 | 22,200 | Jun 2, 2025 |
| May 30, 2025 | VIR Vir Biotechnology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +16,000 | $0.00 | $0 | 16,000 | Jun 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.